Select Medical adds merger proxy disclosures amid shareholder litigation over $20/share buyout

Filed June 22, 2026 · Period ending June 22, 2026 · ~1 min read

Key Changes

• medium

  Three lawsuits and eleven demand letters filed by shareholders allege the merger proxy omits material information; company denies wrongdoing but provides supplemental disclosures to avoid litigation delays.

  Item 8.01 verify on EDGAR →
• medium

  Executive Chairman Ortenzio to receive $2.9M and Senior EVP Jackson $0.2M in transaction fees after closing, in addition to previously disclosed change-in-control payments, for their roles structuring the buyout.

  Item 8.01 verify on EDGAR →
• medium

  Goldman Sachs contacted nine alternative bidders in January 2026; seven declined and two did not respond, indicating limited competitive interest in acquiring the company.

  Item 8.01 verify on EDGAR →